Henry Schein, Inc.

HSIC Healthcare Medical Distribution

Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024. In the quarter to June 2026, revenue grew 6.73%, EPS grew 16.9%, free cash flow grew 140.9% and total debt rose 15.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.

86.38 0.61 −0.70%
Market cap
$9.7B
P/E
25.0×
Fwd P/E
18.5×
Dividend yield
—
F-score
5/9
Altman Z
2.66
Beneish M
−2.51
Dividend safety
69/100

Henry Schein, Inc. (HSIC) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, Henry Schein, Inc. (HSIC) trades at a P/B ratio of 2.6×. Over the past ten years it has ranged from 1.8× (March 2020) to 4.1× (June 2017); the current reading is higher than 41% of that period. That is above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 2.3× 7.59%
FY2024 2.2× (5.41%)
FY2023 2.3× (13.00%)
FY2022 2.6× (1.06%)
FY2021 2.7× 11.79%
FY2020 2.4× (11.98%)
FY2019 2.7× 2.36%
FY2018 2.7× (14.69%)
FY2017 3.1× (11.84%)
FY2016 3.5× (0.89%)

Quarterly newest first

Period P/B ratio Change
Jun 2026 2.5× 14.85%
Mar 2026 2.2× (7.70%)
Dec 2025 2.3× 18.10%
Sep 2025 2.0× (8.99%)
42 more quarters

Against its own ten years

Low 1.8× High 4.1×
Ten-year median 2.7×
Current reading's percentile 45

P/B ratio against peers

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on HSIC